Teva and Takeda form joint venture in Japan to market generic drugs

• Teva Pharmaceutical Industries (TEVA +0.5%) and Takeda Pharmaceutical Company Limited (OTCPK:TKPHF)(TKPYY) establish a venture in Japan with the aim of marketing off-patent (generic) drugs. The Nagoya-based company, called Teva Takeda Yakuhin Ltd., will be led by industry veteran Hiroshi Matsumori.
• Takeda expects the venture to be both earnings and cash flow accretive this year and thereafter. Teva expects accretion to non-GAAP EPS this year as well.
• Now read Teva: The Future is Generic